| Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps CN Jenne, CHY Wong, FJ Zemp, B McDonald, MM Rahman, PA Forsyth, ... Cell host & microbe 13 (2), 169-180, 2013 | 537 | 2013 |
| Modulation of NF-κB signalling by microbial pathogens MM Rahman, G McFadden Nature Reviews Microbiology 9 (4), 291-306, 2011 | 474 | 2011 |
| Modulation of tumor necrosis factor by microbial pathogens MM Rahman, G McFadden PLoS pathogens 2 (2), e4, 2006 | 300 | 2006 |
| The wide utility of rabbits as models of human diseases PJ Esteves, J Abrantes, HM Baldauf, L BenMohamed, Y Chen, ... Experimental & molecular medicine 50 (5), 1-10, 2018 | 184 | 2018 |
| Cytokine determinants of viral tropism G McFadden, MR Mohamed, MM Rahman, E Bartee Nature Reviews Immunology 9 (9), 645-655, 2009 | 170 | 2009 |
| Parallel adaptation of rabbit populations to myxoma virus JM Alves, M Carneiro, JY Cheng, AL de Matos, MM Rahman, L Loog, ... Science 363 (6433), 1319-1326, 2019 | 167 | 2019 |
| Systemic and in vitro infection process of Bombyx mori nucleopolyhedrovirus MM Rahman, KP Gopinathan Virus research 101 (2), 109-118, 2004 | 147 | 2004 |
| A sodium channel mutation causing epilepsy in man exhibits subtle defects in fast inactivation and activation in vitro AK Alekov, MM Rahman, N Mitrovic, F LehmannHorn, H Lerche The Journal of Physiology 529 (3), 533-540, 2000 | 127 | 2000 |
| Myxoma Virus Virotherapy for Glioma in Immunocompetent Animal Models: Optimizing Administration Routes and Synergy with RapamycinOptimizing Myxoma Virotherapy for Malignant Glioma XQ Lun, T Alain, FJ Zemp, H Zhou, MM Rahman, MG Hamilton, ... Cancer research 70 (2), 598-608, 2010 | 122 | 2010 |
| Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy MM Rahman, G McFadden Cancers 13 (21), 5452, 2021 | 120 | 2021 |
| RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages F Wang, X Gao, JW Barrett, Q Shao, E Bartee, MR Mohamed, M Rahman, ... PLoS pathogens 4 (7), e1000099, 2008 | 118 | 2008 |
| Poxvirus host range genes SJ Werden, MM Rahman, G McFadden Advances in virus research 71, 135-171, 2008 | 112 | 2008 |
| Oncolytic myxoma virus: the path to clinic WM Chan, MM Rahman, G McFadden Vaccine 31 (39), 4252-4258, 2013 | 102 | 2013 |
| Enhanced inactivation and acceleration of activation of the sodium channel associated with epilepsy in man AK Alekov, MDM Rahman, N Mitrovic, F Lehmann‐Horn, H Lerche European Journal of Neuroscience 13 (11), 2171-2176, 2001 | 94 | 2001 |
| Co-regulation of NF-κB and inflammasome-mediated inflammatory responses by myxoma virus pyrin domain-containing protein M013 MM Rahman, MR Mohamed, M Kim, S Smallwood, G McFadden PLoS pathogens 5 (10), e1000635, 2009 | 89 | 2009 |
| Oncolytic virotherapy with myxoma virus MM Rahman, G McFadden Journal of clinical medicine 9 (1), 171, 2020 | 88 | 2020 |
| A class of viral inducer of degradation of the necroptosis adaptor RIPK3 regulates virus-induced inflammation Z Liu, H Nailwal, J Rector, MM Rahman, R Sam, G McFadden, FKM Chan Immunity 54 (2), 247-258. e7, 2021 | 81 | 2021 |
| Myxoma virus: propagation, purification, quantification, and storage SE Smallwood, MM Rahman, DW Smith, G McFadden Current protocols in microbiology 17 (1), 14A. 1.1-14A. 1.20, 2010 | 79 | 2010 |
| Myxoma virus protein M029 is a dual function immunomodulator that inhibits PKR and also conscripts RHA/DHX9 to promote expanded host tropism and viral replication MM Rahman, J Liu, WM Chan, S Rothenburg, G McFadden PLoS pathogens 9 (7), e1003465, 2013 | 78 | 2013 |
| Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer ST Wennier, J Liu, S Li, MM Rahman, M Mona, G McFadden Molecular Therapy 20 (4), 759-768, 2012 | 76 | 2012 |
Mohamed R. MohamedProfessor of Biochemistry and Molecular Biology, Faculty of Science, Ain Shams UniversityVerified email at sci.asu.edu.eg